MIM
ARVN icon

MetLife Investment Management’s Arvinas ARVN Stock Holding History

MetLife Investment Management’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Sell
33,035
-775
-2% -$9.6K ﹤0.01% 1930
2025
Q4 		$401K Buy
33,810
+1,381
+4% +$15.1K ﹤0.01% 1896
2025
Q3 		$276K Sell
32,429
-6,397
-16% -$48.5K ﹤0.01% 2131
2025
Q2 		$286K Hold
38,826
– – ﹤0.01% 1985
2025
Q1 		$273K Sell
38,826
-611
-2% -$9.57K ﹤0.01% 2028
2024
Q4 		$756K Buy
39,437
+2,257
+6% +$54.8K ﹤0.01% 1565
2024
Q3 		$916K Hold
37,180
– – 0.01% 1440
2024
Q2 		$990K Buy
37,180
+10,997
+42% +$350K 0.01% 1354
2024
Q1 		$1.08M Hold
26,183
– – 0.01% 1255
2023
Q4 		$1.08M Hold
26,183
– – 0.01% 1257
2023
Q3 		$514K Hold
26,183
– – ﹤0.01% 1616
2023
Q2 		$650K Buy
26,183
+833
+3% +$21.4K ﹤0.01% 1526
2023
Q1 		$693K Hold
25,350
– – 0.01% 1442
2022
Q4 		$867K Hold
25,350
– – 0.01% 1285
2022
Q3 		$1.13M Hold
25,350
– – 0.01% 1125
2022
Q2 		$1.07M Hold
25,350
– – 0.01% 1172
2022
Q1 		$1.71M Buy
25,350
+9,039
+55% +$616K 0.01% 1061
2021
Q4 		$1.34M Buy
16,311
+629
+4% +$51.2K 0.01% 1009
2021
Q3 		$1.29M Hold
15,682
– – 0.01% 1012
2021
Q2 		$1.21M Buy
15,682
+2,396
+18% +$166K 0.01% 1072
2021
Q1 		$878K Hold
13,286
– – 0.01% 1219
2020
Q4 		$1.13M Hold
13,286
– – 0.01% 1075
2020
Q3 		$314K Hold
13,286
– – ﹤0.01% 1607
2020
Q2 		$446K Buy
13,286
+4,500
+51% +$191K 0.01% 1448
2020
Q1 		$354K Hold
8,786
– – ﹤0.01% 1397
2019
Q4 		$361K Hold
8,786
– – ﹤0.01% 1636
2019
Q3 		$189K Hold
8,786
– – ﹤0.01% 1984
2019
Q2 		$193K Buy
+8,786
New +$185K ﹤0.01% 2044

Other funds holding ARVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's ARVN Position: Q1 2026 in Review

MetLife Investment Management reduced its Arvinas (ARVN) stake by 2.3% in Q1 2026, selling an estimated $9.6K and leaving 33,035 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

MetLife Investment Management first reported a position in ARVN in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.71M in Q1 2022. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

  • MetLife Investment Management held 33,035 shares of Arvinas worth $350K as of Q1 2026.
  • MetLife Investment Management sold 775 Arvinas shares in Q1 2026, an estimated $9.6K.
  • Arvinas made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1930 holding.
  • MetLife Investment Management first reported a position in Arvinas in Q2 2019 and has held it in 28 quarters since.
  • MetLife Investment Management's Arvinas position peaked at $1.71M in Q1 2022.
  • 206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.